Jeil Pharmaceutical Co., Ltd.

South Korea

https://www.jeilpharm.co.kr/

Drug Product

Others

Advanced Modalities

Regulatory, Tech Transfer & Support Services

Qualification/Validation Services

Excipients & Specialty Ingredients

Company Overview

About

Jeil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company headquartered in Seoul that offers APIs, finished dosage products, and CMO services. The company has a production capacity of 1.5 billion oral dosage units per year and manufactures tablets, transdermal patches, and other dosage forms. Jeil supplies 62 products including APIs, excipients, and intermediates and is FDA-registered.

Key Expertise

oral solid dose manufacturing, transdermal patch technology, API supply, high-volume tablet production

Therapeutic Areas

Cardiovascular

Quick Facts

HQ:South Korea

Capabilities & Services

Core Capabilities

Small Molecule Drug Product
Small Molecule API
Oral Solid Dose

Dosage Forms

Oral Solid Dose

Topical / Transdermal

Production Scales

Commercial Scale

Large Scale (Metric Ton+)

Annual Capacity

Large Commercial (> 10,000 kg/year)

Markets Served

Asia

Manufacturing Facilities

1 site worldwide